(Business Standard) In an advance towards an effective treatment against the deadly Ebola virus disease, researchers have found that an antiviral compound that blocks the virus's ability to replicate can fully protect monkeys when treated three days after infection.
The findings, published in the journal Nature, suggest that the compound, known as GS-5734, should be further developed as a potential treatment.
GET FREE EBOLA E-BOOK RIGHT NOW! Jane Orient, M.D., chief of the Association of American Physicians and Surgeons, has written a comprehensive and crystal-clear e-book on how to protect yourself and your loved ones from Ebola. It is available FREE, exclusively to subscribers to WND's email news alerts. Sign up now for FREE – and you can immediately download Dr. Orient's e-book, "The Truth About Ebola."
Advertisement - story continues below
"It inhibits Ebola virus by blocking the virus's ability to replicate its own genetic material," said study first author Travis Warren, principal investigator at the US Army Medical Research Institute of Infectious Diseases (USAMRIID).